233 related articles for article (PubMed ID: 26202817)
1. Advantages and Disadvantages of Different Implementation Strategies of Non-Invasive Prenatal Testing in Down Syndrome Screening Programmes.
Mersy E; de Die-Smulders CE; Coumans AB; Smits LJ; de Wert GM; Frints SG; Veltman JA
Public Health Genomics; 2015; 18(5):260-71. PubMed ID: 26202817
[TBL] [Abstract][Full Text] [Related]
2. The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis.
Beulen L; Grutters JP; Faas BH; Feenstra I; van Vugt JM; Bekker MN
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():53-61. PubMed ID: 25238658
[TBL] [Abstract][Full Text] [Related]
3. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
O'Leary P; Maxwell S; Murch A; Hendrie D
Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
[TBL] [Abstract][Full Text] [Related]
4. Women's preference for non-invasive prenatal DNA testing versus chromosomal microarray after screening for Down syndrome: a prospective study.
Cheng Y; Leung WC; Leung TY; Choy KW; Chiu R; Lo TK; Kwok KY; Sahota DS
BJOG; 2018 Mar; 125(4):451-459. PubMed ID: 29125674
[TBL] [Abstract][Full Text] [Related]
5. From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan.
Shaw SW; Chen CP; Cheng PJ
Taiwan J Obstet Gynecol; 2013 Dec; 52(4):470-4. PubMed ID: 24411028
[TBL] [Abstract][Full Text] [Related]
6. Obstetric professionals' perceptions of non-invasive prenatal testing for Down syndrome: clinical usefulness compared with existing tests and ethical implications.
Ngan OMY; Yi H; Wong SYS; Sahota D; Ahmed S
BMC Pregnancy Childbirth; 2017 Sep; 17(1):285. PubMed ID: 28870159
[TBL] [Abstract][Full Text] [Related]
7. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.
Chitty LS; Wright D; Hill M; Verhoef TI; Daley R; Lewis C; Mason S; McKay F; Jenkins L; Howarth A; Cameron L; McEwan A; Fisher J; Kroese M; Morris S
BMJ; 2016 Jul; 354():i3426. PubMed ID: 27378786
[TBL] [Abstract][Full Text] [Related]
8. Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell free fetal DNA in the UK National Health Service.
Morris S; Karlsen S; Chung N; Hill M; Chitty LS
PLoS One; 2014; 9(4):e93559. PubMed ID: 24714162
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of preferences of women and healthcare professionals in Singapore for implementation of noninvasive prenatal testing for Down syndrome.
Barrett AN; Advani HV; Chitty LS; Su LL; Biswas A; Tan WC; Hill M; Choolani M
Singapore Med J; 2017 Jun; 58(6):298-310. PubMed ID: 27357315
[TBL] [Abstract][Full Text] [Related]
10. Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis.
Neyt M; Hulstaert F; Gyselaers W
BMJ Open; 2014 Nov; 4(11):e005922. PubMed ID: 25380810
[TBL] [Abstract][Full Text] [Related]
11. [Non-invasive prenatal testing: challenges for future implementation].
Henneman L; Page-Chrisiaens GC; Oepkes D
Ned Tijdschr Geneeskd; 2015; 159():A9479. PubMed ID: 26530119
[TBL] [Abstract][Full Text] [Related]
12. Uptake of fetal aneuploidy screening after the introduction of the non-invasive prenatal test: A national population-based register study.
van der Meij KRM; de Groot-van Mooren M; Carbo EWS; Pieters MJ; Rodenburg W; Sistermans EA; Cornel MC; Henneman L;
Acta Obstet Gynecol Scand; 2021 Jul; 100(7):1265-1272. PubMed ID: 33465829
[TBL] [Abstract][Full Text] [Related]
13. Economic analysis of prenatal screening strategies for Down syndrome in singleton pregnancies in Turkey.
Ökem ZG; Örgül G; Kasnakoglu BT; Çakar M; Beksaç MS
Eur J Obstet Gynecol Reprod Biol; 2017 Dec; 219():40-44. PubMed ID: 29040895
[TBL] [Abstract][Full Text] [Related]
14. Chorionic Villus Sampling, Early Amniocentesis, and Termination of Pregnancy Without Diagnostic Testing: Comparison of Fetal Risk Following Positive Non-invasive Prenatal Testing.
Zelig CM; Knutzen DM; Ennen CS; Dolinsky BM; Napolitano PG
J Obstet Gynaecol Can; 2016 May; 38(5):441-445.e2. PubMed ID: 27261219
[TBL] [Abstract][Full Text] [Related]
15. The role of noninvasive prenatal testing as a diagnostic versus a screening tool--a cost-effectiveness analysis.
Ohno M; Caughey A
Prenat Diagn; 2013 Jul; 33(7):630-5. PubMed ID: 23674316
[TBL] [Abstract][Full Text] [Related]
16. A cost-effectiveness analysis comparing different strategies to implement noninvasive prenatal testing into a Down syndrome screening program.
Ayres AC; Whitty JA; Ellwood DA
Aust N Z J Obstet Gynaecol; 2014 Oct; 54(5):412-7. PubMed ID: 25196262
[TBL] [Abstract][Full Text] [Related]
17. 1p deletion syndrome: A prenatal diagnosis characterized by an abnormal 1st trimester combined screening test, yet a normal NIPT result.
Yang CY; Kao CC; Chang SD; Huang SY
Taiwan J Obstet Gynecol; 2018 Feb; 57(1):106-109. PubMed ID: 29458877
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive prenatal testing for fetal trisomy in a mixed risk factors pregnancy population.
Li WH; Wang PH; Chuang CM; Chang YW; Yang MJ; Chen CY; Chao KC; Yen MS
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):122-5. PubMed ID: 25951714
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of prenatal screening and diagnostic strategies for Down syndrome: A microsimulation modeling analysis.
Zhang W; Mohammadi T; Sou J; Anis AH
PLoS One; 2019; 14(12):e0225281. PubMed ID: 31800591
[TBL] [Abstract][Full Text] [Related]
20. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
